Industry Insights
MicroTissue: Transforming Drug Discovery
Industry InsightWe spoke to Ping Yeh, CEO of StemoniX, to learn more about the company and their mission. With an aim to accelerate and optimize drug discovery and development, StemoniX creates ‘ready-to-use’ microtissue plates that mimic the native organ tissue.
Read More
Overcoming Challenges in Single Cell Analysis
Industry InsightBD Biosciences has developed a method with the potential to transform both single cell transcriptional profiling and high parameter proteomics
Read More
The Future of Toxicology: An Industry Case Study
Industry InsightThis article describes some new in vitro approaches to toxicology, as well as current initiatives, to facilitate the verification of methods and conclusions, and to enhance data sharing and scientific discovery.
Read More
Uncovering the Dark Matter of Microbiota
Industry InsightWe spoke to Dirk Löffert, Ph.D., CEO of Biomillenia, to learn about some of the challenges of isolating live bacterial species, and how microbiome-on-a-chip technology can help overcome some of these.
Read More
Unlocking The Full Potential of Organoids
Industry InsightTo learn about the importance of the extracellular matrix and some of the limitations of current organoid culture systems, we spoke to Colin Sanctuary, CEO and founder of QGel, a spin-out from EPFL.
Read More
In Vitro Toxicology Testing: Dismantling the Barriers via Collaboration
Industry InsightPromoting the adoption of in vitro toxicity testing is an important undertaking, so we should strive to overcome the barriers preventing its widespread adoption. Already, collaborative efforts have made progress in this regard, and research advances are increasingly demonstrating the potential of in vitro biomimetic liver models.
Read More
In Vitro Toxicology Testing: The Barriers to Progression and Adoption
Industry InsightThe field of toxicology as a whole is at a crossroads where current and future technologies are enabling better predictions of toxicity before a substance is released for human consumption or exposure. While a few barriers remain, we are making progress towards overcoming them, from both technical and policy perspectives.
Read More
Cell-based Imaging and Screening Applications
Industry InsightBioStatus develops and supplies products for cell-based imaging, cytometry and screening applications. We met with Roy Edward, Director at BioStatus during the High Content and Phenotypic Screening 2017 event to learn more.
Read More
A New Approach to Treating Hair Loss
Industry InsightWe spoke to Lee Buckler, President and CEO of RepliCel, to learn about the cellular mechanisms responsible for hair loss, and the potential that cell therapy could offer to treat the condition.
Read More
Cell Culture: Moving from 2D to 3D and Beyond
Industry InsightTo learn about the limitations of 2D cell culture models, the range of 3D tools available, and some of the advantages they can bring to researchers, we spoke to Dr. Richard Eglen, Vice President and General Manager of Corning Life Sciences.
Read More
